Thrombocythemia, Essential
"Thrombocythemia, Essential" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A clinical syndrome characterized by repeated spontaneous hemorrhages and a remarkable increase in the number of circulating platelets.
Descriptor ID |
D013920
|
MeSH Number(s) |
C15.378.100.832 C15.378.140.860.800 C15.378.190.636.860.800 C15.378.463.825
|
Concept/Terms |
Thrombocythemia, Essential- Thrombocythemia, Essential
- Essential Thrombocythemia
- Essential Thrombocythemias
- Thrombocythemias, Essential
- Thrombocythemia, Hemorrhagic
- Primary Thrombocythemia
- Thrombocythemia, Primary
- Primary Thrombocythemias
- Thrombocythemias, Primary
- Thrombocytosis, Primary
- Primary Thrombocytoses
- Primary Thrombocytosis
- Thrombocytoses, Primary
- Hemorrhagic Thrombocythemia
- Hemorrhagic Thrombocythemias
- Thrombocythemias, Hemorrhagic
- Thrombocythemia, Idiopathic
- Idiopathic Thrombocythemia
- Idiopathic Thrombocythemias
- Thrombocythemias, Idiopathic
Thrombocytosis, Autosomal Dominant- Thrombocytosis, Autosomal Dominant
- Autosomal Dominant Thrombocytoses
- Autosomal Dominant Thrombocytosis
- Dominant Thrombocytoses, Autosomal
- Dominant Thrombocytosis, Autosomal
- Thrombocytoses, Autosomal Dominant
|
Below are MeSH descriptors whose meaning is more general than "Thrombocythemia, Essential".
Below are MeSH descriptors whose meaning is more specific than "Thrombocythemia, Essential".
This graph shows the total number of publications written about "Thrombocythemia, Essential" by people in this website by year, and whether "Thrombocythemia, Essential" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1999 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Thrombocythemia, Essential" by people in Profiles.
-
Cost-effectiveness model of a phase II clinical trial of a new pharmaceutical for essential thrombocythemia: is it helpful to policy makers? Semin Hematol. 1999 Jan; 36(1 Suppl 2):26-9.
-
The role of apheresis in the support of life-threatening ITP relapse. Am J Med Sci. 1987 Dec; 294(6):444-7.